Hypervision Surgical raised £17M in a Series A round announced on April 30, 2026. Hypervision Surgical develops computer-assisted tissue analysis tools for surgeons.
Hypervision Surgical develops computer-assisted tissue analysis tools for surgeons.
Hypervision Surgical, based in London, United Kingdom, announced £17M in Series A financing on April 30, 2026.
Participants include Redalpine, LifeX Ventures, Heran Partners, ZEISS Ventures, Angelini Ventures, SINC Fund managed by SAGES Ingenuity.
A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer.
Subra is a Danish deep-tech developing revolutionary superconductor solutions for zero-loss power transmission and fusion energy.
Germany-based startup developing and manufacturing technology for space.